Cargando…

Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014

BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of mortality and morbidity in many countries but few recent large-scale studies have examined trends in its incidence. METHODS: Incidence of CAP leading to hospitalisation in one UK region (Oxfordshire) was calculated over calendar time...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quan, T Phuong, Fawcett, Nicola J, Wrightson, John M, Finney, John, Wyllie, David, Jeffery, Katie, Jones, Nicola, Shine, Brian, Clarke, Lorraine, Crook, Derrick, Walker, A Sarah, Peto, Timothy E A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893127/ https://www.ncbi.nlm.nih.gov/pubmed/26888780 http://dx.doi.org/10.1136/thoraxjnl-2015-207688

Ejemplares similares

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England
por: Campling, James, et al.
Publicado: (2020)

Molecular epidemiological study of enterovirus D68 in hospitalised children in Hong Kong in 2014–2015 and their complete coding sequences
por: Wang, Haichao, et al.
Publicado: (2019)

Impact of social deprivation on clinical outcomes of adults hospitalised with community-acquired pneumonia in England: a retrospective cohort study
por: Lawrence, Hannah, et al.
Publicado: (2022)

Shift work is associated with positive COVID-19 status in hospitalised patients
por: Maidstone, Robert, et al.
Publicado: (2021)

Impact of corticosteroids in hospitalised COVID-19 patients
por: Ho, Kam Sing, et al.
Publicado: (2021)

Association of smoking status with outcomes in hospitalised patients with COVID-19
por: Adrish, Muhammad, et al.
Publicado: (2020)

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis
por: Dawson, Camilla, et al.
Publicado: (2023)

Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study
por: Yousufuddin, Mohammed, et al.
Publicado: (2021)

Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area
por: Sapey, Elizabeth, et al.
Publicado: (2020)

Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study
por: Wilcox, Christopher R, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study
por: Lee, Terry, et al.
Publicado: (2023)

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
por: Berenguer, Juan, et al.
Publicado: (2021)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2021)

Serum levels of immunoglobulins and severity of community-acquired pneumonia
por: de la Torre, Mari C, et al.
Publicado: (2016)

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
por: Nguyen-Van-Tam, J S, et al.
Publicado: (2010)

Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database
por: Ouattara, Eric, et al.
Publicado: (2021)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
por: Stirrup, Oliver, et al.
Publicado: (2021)

Early identification of severe community-acquired pneumonia: a retrospective observational study
por: Grudzinska, Frances S, et al.
Publicado: (2019)

Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
por: Dwyer, Richard, et al.
Publicado: (2014)

Chest radiograph-based artificial intelligence predictive model for mortality in community-acquired pneumonia
por: Quah, Jessica, et al.
Publicado: (2021)

The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case–control study
por: Bhuiyan, Mejbah Uddin, et al.
Publicado: (2019)

British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
por: Lim, W S, et al.
Publicado: (2015)

Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data
por: Fujikura, Yuji, et al.
Publicado: (2023)

Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults (NEUMO-ES-RISK project)
por: Rivero-Calle, Irene, et al.
Publicado: (2019)

Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
por: Ao, Zhi, et al.
Publicado: (2023)

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Experiences of nurses caring for respiratory patients during the first wave of the COVID-19 pandemic: an online survey study
por: Roberts, Nicola J, et al.
Publicado: (2021)

Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
por: LeBlanc, Jason, et al.
Publicado: (2020)

Emergency department visits and hospitalisations for emergent asthmatic symptoms from 2014 to 2016: cross-sectional study in Korea
por: Choi, Kyungseon, et al.
Publicado: (2020)

TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial
por: Ware, Lorraine B, et al.
Publicado: (2023)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia
por: Conway Morris, Andrew, et al.
Publicado: (2010)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract
por: Moncayo-Nieto, Olga Lucia, et al.
Publicado: (2014)

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data
por: Hedberg, Pontus, et al.
Publicado: (2022)

TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection
por: Pearson, Hayley, et al.
Publicado: (2021)

Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors
por: Saigal, Anita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bm5rdbsg3kts9qdav2tt9hhmkg